サイクリンD3
Mol. Cell. Biol. 19 (1): 353–63. (1999). doi:10.1128/mcb.19.1.353. PMC 83893. PMID 9858559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC83893/.
“A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay”. J. Biol. Chem. 274 (20): 13961–9. (1999). doi:10.1074/jbc.274.20.13961. PMID 10318807.
“Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis”. Endocrinology 140 (6): 2790–800. (1999). doi:10.1210/endo.140.6.6756. PMID 10342870.
16 (7): 3934–44. (1996). doi:10.1128/MCB.16.7.3934. PMC 231390. PMID 8668211. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC231390/.
“Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1”. Mol. Cell. Biol. 16 (11): 6457–67. (1996). doi:10.1128/MCB.16.11.6457. PMC 231647. PMID 8887674. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC231647/.
“Cyclin D3 expression in normal, reactive and neoplastic tissues”. J. Pathol. 185 (2): 159–66. (1998). doi:10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0. PMID 9713342.
“Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo”.